Scientech Research LLC’s Cardio Diagnostics CDIO Stock Holding History

Scientech Research LLC’s Portfolio CDIO Stock Details CDIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-13,880	Closed	-$27.1K	–	286
2026 Q1	$27.1K	Buy	+13,880	New	+$36.3K	0.02%	431
2025 Q1	–	Sell	-1,150	Closed	-$31.6K	–	597
2024 Q4	$31.6K	Buy	+1,150	New	+$15.9K	0.01%	522

Other funds holding CDIO

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Scientech Research LLC's CDIO Position: Q2 2026 in Review

Scientech Research LLC sold out of Cardio Diagnostics (CDIO) in Q2 2026, closing a stake of 13,880 shares — an estimated $27.1K sold.

Scientech Research LLC first reported a position in CDIO in Q4 2024 and held it in 2 quarters. The position peaked at $31.6K in Q4 2024. 17 funds tracked by Wall St. Rank hold CDIO as of Q2 2026.

Scientech Research LLC reported no remaining Cardio Diagnostics position as of Q2 2026 after selling out during the quarter.
Scientech Research LLC sold 13,880 Cardio Diagnostics shares in Q2 2026, an estimated $27.1K.
Scientech Research LLC first reported a position in Cardio Diagnostics in Q4 2024 and held it in 2 quarters.
Scientech Research LLC's Cardio Diagnostics position peaked at $31.6K in Q4 2024.
17 funds tracked by Wall St. Rank held Cardio Diagnostics as of Q2 2026.

Based on Scientech Research LLC's 13F filing for Q2 2026, filed 14 Aug 2026.